Midgard Science

ImpriMed

Palo Alto, CA, United States imprimedicine.com

From their website, Nov 2026

Work here? Claim this listing

About

ImpriMed provides AI-driven precision medicine services for veterinary oncology, human blood-cancer oncology, and pharmaceutical CRO clients. It works with veterinarians, physicians, oncologists, and pharmaceutical companies from Palo Alto, California.

Services

  • Veterinary precision medicine

    Provides personalized drug response predictions for canine and feline blood cancers.

  • Human precision medicine

    Predicts patient-specific drug responses using precision analytics for human oncology.

  • Ex vivo CRO services for pharma

    Uses live-cell-based analytics to support oncology drug development programs.

  • Combination optimization

    Ranks synergistic regimens in primary patient cells.

  • Drug-resistance profiling

    Evaluates activity where standard of care fails.

  • Biomarker validation

    Tests candidate markers for use in enrichment rules.

  • Translational immunotherapy

    Measures antigen, engagement, and killing in patient cells.

  • Flow cytometry panels

    Offers add-on flow cytometry panel analysis.

  • Sequencing and transcriptomics

    Offers sequencing and transcriptomics as add-on modules.

  • Cryopreservation and biobanking

    Provides cryopreservation and biobanking as an add-on module.

  • Personalized prediction profile

    Provides veterinary response prediction reports.

  • Flow cytometry and CHOP predictions

    Provides veterinary flow cytometry and CHOP-related prediction services.

  • Immunoprofile flow cytometry

    Provides veterinary immunoprofiling by flow cytometry.

  • PARR

    Offers PARR testing for veterinary services.

  • Multidrug sensitivity genotyping (MDR1)

    Offers MDR1 genotyping for veterinary services.

  • Cytology

    Offers cytology for veterinary services.

Turnaround
Within 1-2 business days
What to send
Single primary patient sample · Primary patient cells

Capabilities

Assays and studies
Flow cytometry · NGS · Bispecifics · ADCs · Peptides · Oligonucleotides · Small molecules · Ex vivo drug sensitivity · Dose-response · AUC · E max · Drug combination synergy
8 moreSynergy scoring · Antagonism scoring · Multiparameter flow cytometry · Drug effect · Antigen density · Target engagement · Malignant vs. normal selectivity · ML-integrated analysis
Scale and capacity
Single primary patient sample · 20+ drug standard panel
Therapeutic areas
Oncology · Veterinary oncology · Blood cancers · Acute myeloid leukemia · Acute lymphoblastic leukemia · Non-Hodgkin lymphoma · Multiple myeloma · Myelodysplastic syndromes · Comparative oncology

Instruments and platforms

  • Flow cytometry

Modalities and species

Modalities
Small molecule · Bispecific · ADC · Peptide · Oligonucleotide
Species and models
Canine · Feline · Primary patient cells · Primary human cells · Blood-cancer patient cells · Blast compartments · Stem-cell compartments · Differentiated compartments · Immune compartments

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO/IEC 17025Self-reported

  • CLIASelf-reported

Company

Type
CRO
Quality
FDA Modernization Act 2.0 (2022) (human-derived, cell-based functional data)

Locations

Based in
Palo Alto, CA, United States
Sites
Palo Alto, USA

Public records

Biocom California CRO directory
Biomarker Discovery & Validation, Ex vivo drug sensitivity testing, Patient Stratification, Translational Oncology CRO source

Similar labs

Work here? Claim this listing